Outlook Therapeutics Inc (NASDAQ:OTLK)

1.30
Delayed Data
As of Oct 17
 -0.06 / -4.41%
Today’s Change
0.85
Today|||52-Week Range
10.96
-67.50%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Outlook Therapeutics Inc have a median target of 8.50, with a high estimate of 12.00 and a low estimate of 4.00. The median estimate represents a +553.85% increase from the last price of 1.30.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Outlook Therapeutics Inc. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.31
Sales
$637.5K
Reporting Date
Dec 17

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -29.17%
 
 
 
 
 
 
Growthannually 73.77%
 
 
 
 
 

Sales

Growthquarterly 9.16%
 
 
 
 
 
 
Growthannually -4.12%
 
 
 
 
Key to the earnings and sales forecast charts.